Back to Agenda
Product Crisis Management: Crisis, What Crisis?
Session Chair(s)
Mariette Boerstoel-Streefland, MD, MBA, MS
Senior Vice President, Patient Safety Officer , Bristol Myers Squibb, United States
Pharmacovigilance: Planning for a Pandemic
Learning Objective : Explain what constitutes a product crisis; Describe the best practices in the pharmaceutical industry to manage a product crisis; Discuss how to arrive at an effective crisis communication plan; Determine who are the players in case of a crisis; Describe what is being done in other industries including what can be learned by the pharmaceutical industry.
Speaker(s)
Cesare Pinto
Director, Medical Information Services, Bayer HealthCare Pharmaceuticals, United States
Planning for the Unexpected: Product Crisis Management
Gil Bashe
Managing Partner, Chair, Global Health, FINN Partners, United States
Dousing the Flames: Audience-Directed Interventions for Crisis Communications
Libbie Parker McKenzie, MD
VP Lifecycle Safety Mgmt; Global Head, Safety Surveillance and Benefit-Risk Mgmt, Quintiles Transnational Corp. , United States
Pharmacovigilance: Planning for a Pandemic
Have an account?